Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-11 5:35 pm Unchanged | 2025-07-11 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,541,764 6.300% | 0 (Unchanged) | Filing History |
| 2025-06-13 6:26 pm Purchase | 2025-06-11 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,541,764 6.300% | 2,308 (+0.05%) | Filing History |
| 2025-04-24 5:00 pm Purchase | 2025-04-23 | 13D | SINOVAC BIOTECH LTD SVA | Vivo Capital VIII, LLC | 4,539,456 6.300% | 4,539,456 (New Position) | Filing History |
| 2024-02-13 5:00 pm Sale | 2023-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII, LLC | 103,650 5.500% | -10,000 (-8.80%) | Filing History |
| 2023-02-13 5:57 pm Purchase | 2022-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Capital VIII, LLC | 4,340,212 9.000% | 4,340,212 (New Position) | Filing History |
| 2023-02-13 5:56 pm Sale | 2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Vivo Capital VIII, LLC | 2,571,024 4.300% | -1,729,237 (-40.21%) | Filing History |
| 2022-02-11 5:24 pm Purchase | 2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | Vivo Capital VIII, LLC | 4,300,261 7.400% | 4,300,261 (New Position) | Filing History |
| 2022-02-11 5:22 pm Sale | 2021-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII, LLC | 0 0.000% | -1,819,600 (Position Closed) | Filing History |
| 2022-02-11 5:21 pm Sale | 2021-12-31 | 13G | AMYRIS INC AMRSQ | Vivo Capital VIII, LLC | 7,734,621 2.500% | -3,110,475 (-28.68%) | Filing History |
| 2021-05-06 4:30 pm Purchase | 2021-04-27 | 13G | IPI LEGACY LIQUIDATION CO COMM IMPLQ | Vivo Capital VIII, LLC | 2,884,789 14.900% | 2,884,789 (New Position) | Filing History |
| 2021-02-18 4:53 pm Purchase | 2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN | Vivo Capital VIII, LLC | 2,317,780 9.700% | 2,317,780 (New Position) | Filing History |
| 2021-02-18 4:50 pm Purchase | 2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT | Vivo Capital VIII, LLC | 113,650 6.600% | 113,650 (New Position) | Filing History |
| 2021-02-12 4:30 pm Purchase | 2020-12-31 | 13G | Passage Bio, Inc. PASG | Vivo Capital VIII, LLC | 74,352 11.000% | 74,352 (New Position) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | AMYRIS INC AMRSQ | Vivo Capital VIII, LLC | 10,845,096 4.500% | -37,560 (-0.35%) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | Vivo Capital VIII, LLC | 1,819,600 5.500% | -425,304 (-18.95%) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | Kadmon Holdings, Inc. KDMN | Vivo Capital VIII, LLC | 4,283,014 2.500% | -4,687,228 (-52.25%) | Filing History |